Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM).

Full DD Report for BSPM

You must become a subscriber to view this report.


Recent News from (NASDAQ: BSPM)

Midday Gainers / Losers (05/04/2018)
Gainers:   BSPM +33% . CVGI +35% . CRC +27% . EARS +26% . P +23% . KONA +23% . NGVC +22% . MED +22% . SHAK +22% . PTLA +21% . More news on: Biostar Pharmaceutic, Commercial Vehicle Group, Inc., California Resources Corporation, Stocks on the move, , ...
Source: SeekingAlpha
Date: May, 04 2018 13:15
Midday Gainers / Losers (04/24/2018)
Gainers: CHEK +69% . ATOS +40% . LEDS +22% . CLDC +20% . SANM +18% . HSII +17% . HLX +16% . SC +16% . MARA +12% . LYL +11% . More news on: Check-Cap Ltd., Atossa Genetics, Inc., SemiLEDs Corporation, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 24 2018 12:40
Midday Gainers / Losers (03/21/2018)
CALI +48% . MARA +26% . DXPE +20% . KMPH +16% . GERN +15% . TGEN +15% . NH +15% . ARNA +13% . PRTA +13% . TCCO +12% . More news on: China Auto Logistics Inc., Marathon Patent Group, Inc., DXP Enterprises, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: March, 21 2018 12:45
Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform
XIANYANG, China, Feb. 21, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced its pla...
Source: PR Newswire
Date: February, 21 2018 09:00
Midday Gainers / Losers (2/7/2018)
Gainers: SNAP +38% . DRYS +28% . TRNC +26% . MODN +26% . TAT +21% . BSPM +18% . WTW +17% . PERY +17% . ABEO +16% . HZN +16% . More news on: Snap Inc., DryShips Inc., tronc, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: February, 07 2018 12:53
Shaanxi Aoxing Pharmaceutical Co., Ltd. Renewed its GMP Certification
XIANYANG, China , Feb. 7, 2018 /PRNewswire/ -- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "the Company"), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions, today announced that its va...
Source: PR Newswire
Date: February, 07 2018 09:00
Premarket Losers as of 9:05 am (2/5/2018)
EYEG   -43%  on announcing  results for Phase 2b trial of EGP-437 in cataract surgery. More news on: EyeGate Pharmaceuticals, Corcept Therapeutics Incorporated, Digital Power Corporation, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: February, 05 2018 09:14
Midday Gainers / Losers (2/2/2018)
Gainers: USAK +23% . CTHR +20% . BSPM +19% . WMLP +16% . VIAV +15% . SCKT +15% . JOUT +15% . ATHN +15% . VKTX +13% . CFMS +12% . More news on: USA Truck, Inc., Charles & Colvard Ltd, Biostar Pharmaceutic, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: February, 02 2018 12:45
Midday Gainers / Losers (2/1/2018)
Gainers: AFMD +40% . QNST +36% . RVLT +31% . LQDT +27% . CMPR +18% . BSPM +18% . OTEX +17% . ACMR +15% . ZN +15% . EBAY +14% . More news on: Affimed Therapeutics, QuinStreet, Inc., Revolution Lighting Technologies, Inc., Stocks on the move, Read more .....
Source: SeekingAlpha
Date: February, 01 2018 12:50
Biostar Pharma Post Huge Gains, Pipeline Review, and a New Product
NEW YORK, NY / ACCESSWIRE / February 1, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report with no obligation on Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM), a company th...
Source: ACCESSWIRE IA
Date: February, 01 2018 08:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-161.96772.092.231.9677184,251
2018-08-151.86561.96962.021.865674,769
2018-08-142.001.992.08991.8580,104
2018-08-131.78542.032.08331.7854130,847
2018-08-101.911.881.97511.835669,954

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1635,63370,18150.7730Short
2018-08-1511,20923,77247.1521Short
2018-08-1428,24033,99183.0808Short
2018-08-1317,83528,92161.6680Short
2018-08-108,02410,12079.2885Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BSPM.


About Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM)

Logo for Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM)

BioStar Pharmaceuticals, Inc., through its wholly owned subsidiary develops, manufactures, and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company s most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over the counter OTC medicine for Chronic hepatitis B, a disease affecting approximately of the Chinese population. In addition to its hepatitis product, BioStar manufactures two broad based OTC products, two prescription based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents.

 

 

 

Current Management

  • Ronghua Wang / CEO
  • Elaine Zhao / CFO
  • Ronghua Wang / Chairman
  • Qinghua Liu /
  • Zibing Zack Pan /
  • Zhongyang Shang /

Current Share Structure

  • Market Cap: $6,672,086 - 05/14/2018
  • Issue and Outstanding: 2,637,188 - 11/20/2017

 


Recent Filings from (NASDAQ: BSPM)

Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 23 2018
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: April, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 28 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 18 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 04 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 20 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 15 2017

 

 


Daily Technical Chart for (NASDAQ: BSPM)

Daily Technical Chart for (NASDAQ: BSPM)


Stay tuned for daily updates and more on (NASDAQ: BSPM)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: BSPM)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BSPM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of BSPM and does not buy, sell, or trade any shares of BSPM. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/